vs
Side-by-side financial comparison of APi Group Corp (APG) and BeOne Medicines Ltd. (ONC). Click either name above to swap in a different company.
APi Group Corp is the larger business by last-quarter revenue ($2.1B vs $1.5B, roughly 1.4× BeOne Medicines Ltd.). APi Group Corp runs the higher net margin — 4.6% vs 4.4%, a 0.1% gap on every dollar of revenue. On growth, BeOne Medicines Ltd. posted the faster year-over-year revenue change (32.8% vs 13.8%). BeOne Medicines Ltd. produced more free cash flow last quarter ($379.8M vs $356.0M). Over the past eight quarters, BeOne Medicines Ltd.'s revenue compounded faster (41.2% CAGR vs 15.0%).
X.AI Corp., doing business as xAI, is an American company working in the area of artificial intelligence (AI), social media and technology that is a wholly owned subsidiary of American aerospace company SpaceX. Founded by Elon Musk in 2023, the company's flagship products are the generative AI chatbot named Grok and the social media platform X, the latter of which they acquired in March 2025.
BeOne Medicines Ltd.ONCEarnings & Financial Report
BeOne Medicines, formerly known as BeiGene, Ltd. is a multinational oncology company. It specializes in the development of drugs for cancer treatment.
APG vs ONC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $2.1B | $1.5B |
| Net Profit | $97.0M | $66.5M |
| Gross Margin | 32.0% | 90.5% |
| Operating Margin | 7.7% | 12.4% |
| Net Margin | 4.6% | 4.4% |
| Revenue YoY | 13.8% | 32.8% |
| Net Profit YoY | 44.8% | 143.8% |
| EPS (diluted) | $-1.16 | $0.05 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $2.1B | $1.5B | ||
| Q3 25 | $2.1B | $1.4B | ||
| Q2 25 | $2.0B | $1.3B | ||
| Q1 25 | $1.7B | $1.1B | ||
| Q4 24 | $1.9B | $1.1B | ||
| Q3 24 | $1.8B | $1.0B | ||
| Q2 24 | $1.7B | $929.2M | ||
| Q1 24 | $1.6B | $751.7M |
| Q4 25 | $97.0M | $66.5M | ||
| Q3 25 | $93.0M | $124.8M | ||
| Q2 25 | $77.0M | $94.3M | ||
| Q1 25 | $35.0M | $1.3M | ||
| Q4 24 | $67.0M | $-151.9M | ||
| Q3 24 | $69.0M | $-121.3M | ||
| Q2 24 | $69.0M | $-120.4M | ||
| Q1 24 | $45.0M | $-251.2M |
| Q4 25 | 32.0% | 90.5% | ||
| Q3 25 | 31.3% | 86.1% | ||
| Q2 25 | 30.9% | 87.5% | ||
| Q1 25 | 31.5% | 85.2% | ||
| Q4 24 | 30.9% | 85.8% | ||
| Q3 24 | 31.1% | 83.0% | ||
| Q2 24 | 31.4% | 85.1% | ||
| Q1 24 | 30.7% | 83.4% |
| Q4 25 | 7.7% | 12.4% | ||
| Q3 25 | 7.8% | 11.5% | ||
| Q2 25 | 7.2% | 6.7% | ||
| Q1 25 | 4.9% | 1.0% | ||
| Q4 24 | 6.2% | -7.0% | ||
| Q3 24 | 7.8% | -12.0% | ||
| Q2 24 | 7.3% | -11.5% | ||
| Q1 24 | 6.2% | -34.8% |
| Q4 25 | 4.6% | 4.4% | ||
| Q3 25 | 4.5% | 8.8% | ||
| Q2 25 | 3.9% | 7.2% | ||
| Q1 25 | 2.0% | 0.1% | ||
| Q4 24 | 3.6% | -13.5% | ||
| Q3 24 | 3.8% | -12.1% | ||
| Q2 24 | 4.0% | -13.0% | ||
| Q1 24 | 2.8% | -33.4% |
| Q4 25 | $-1.16 | $0.05 | ||
| Q3 25 | $0.20 | $0.08 | ||
| Q2 25 | $0.16 | $0.06 | ||
| Q1 25 | $0.11 | $0.00 | ||
| Q4 24 | $0.05 | $-0.10 | ||
| Q3 24 | $0.23 | $-0.09 | ||
| Q2 24 | $0.22 | $-0.09 | ||
| Q1 24 | $-1.34 | $-0.19 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $912.0M | $4.5B |
| Total DebtLower is stronger | $2.8B | $836.4M |
| Stockholders' EquityBook value | $3.4B | $4.4B |
| Total Assets | $8.9B | $8.2B |
| Debt / EquityLower = less leverage | 0.81× | 0.19× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $912.0M | $4.5B | ||
| Q3 25 | $555.0M | $4.0B | ||
| Q2 25 | $432.0M | $2.8B | ||
| Q1 25 | $460.0M | $2.5B | ||
| Q4 24 | $499.0M | $2.6B | ||
| Q3 24 | $487.0M | $2.7B | ||
| Q2 24 | $324.0M | $2.6B | ||
| Q1 24 | $247.0M | $2.8B |
| Q4 25 | $2.8B | $836.4M | ||
| Q3 25 | $2.8B | — | ||
| Q2 25 | $2.8B | — | ||
| Q1 25 | $2.8B | — | ||
| Q4 24 | $2.8B | — | ||
| Q3 24 | $2.9B | — | ||
| Q2 24 | $2.8B | — | ||
| Q1 24 | $2.7B | — |
| Q4 25 | $3.4B | $4.4B | ||
| Q3 25 | $3.3B | $4.1B | ||
| Q2 25 | $3.2B | $3.8B | ||
| Q1 25 | $3.0B | $3.5B | ||
| Q4 24 | $3.0B | $3.3B | ||
| Q3 24 | $3.0B | $3.4B | ||
| Q2 24 | $2.8B | $3.4B | ||
| Q1 24 | $2.3B | $3.4B |
| Q4 25 | $8.9B | $8.2B | ||
| Q3 25 | $8.7B | $7.6B | ||
| Q2 25 | $8.5B | $6.3B | ||
| Q1 25 | $8.1B | $5.8B | ||
| Q4 24 | $8.2B | $5.9B | ||
| Q3 24 | $8.2B | $5.8B | ||
| Q2 24 | $8.0B | $5.7B | ||
| Q1 24 | $7.2B | $5.7B |
| Q4 25 | 0.81× | 0.19× | ||
| Q3 25 | 0.84× | — | ||
| Q2 25 | 0.87× | — | ||
| Q1 25 | 0.92× | — | ||
| Q4 24 | 0.93× | — | ||
| Q3 24 | 0.96× | — | ||
| Q2 24 | 1.00× | — | ||
| Q1 24 | 1.19× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $382.0M | $417.3M |
| Free Cash FlowOCF − Capex | $356.0M | $379.8M |
| FCF MarginFCF / Revenue | 16.8% | 25.4% |
| Capex IntensityCapex / Revenue | 1.2% | 2.5% |
| Cash ConversionOCF / Net Profit | 3.94× | 6.28× |
| TTM Free Cash FlowTrailing 4 quarters | $663.0M | $941.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $382.0M | $417.3M | ||
| Q3 25 | $232.0M | $402.6M | ||
| Q2 25 | $83.0M | $263.6M | ||
| Q1 25 | $62.0M | $44.1M | ||
| Q4 24 | $283.0M | $75.2M | ||
| Q3 24 | $220.0M | $188.4M | ||
| Q2 24 | $110.0M | $-95.6M | ||
| Q1 24 | $7.0M | $-308.6M |
| Q4 25 | $356.0M | $379.8M | ||
| Q3 25 | $201.0M | $354.5M | ||
| Q2 25 | $56.0M | $219.8M | ||
| Q1 25 | $50.0M | $-12.3M | ||
| Q4 24 | $265.0M | $-17.3M | ||
| Q3 24 | $198.0M | $54.7M | ||
| Q2 24 | $88.0M | $-205.5M | ||
| Q1 24 | $-15.0M | $-465.1M |
| Q4 25 | 16.8% | 25.4% | ||
| Q3 25 | 9.6% | 25.1% | ||
| Q2 25 | 2.8% | 16.7% | ||
| Q1 25 | 2.9% | -1.1% | ||
| Q4 24 | 14.2% | -1.5% | ||
| Q3 24 | 10.8% | 5.5% | ||
| Q2 24 | 5.1% | -22.1% | ||
| Q1 24 | -0.9% | -61.9% |
| Q4 25 | 1.2% | 2.5% | ||
| Q3 25 | 1.5% | 3.4% | ||
| Q2 25 | 1.4% | 3.3% | ||
| Q1 25 | 0.7% | 5.0% | ||
| Q4 24 | 1.0% | 8.2% | ||
| Q3 24 | 1.2% | 13.3% | ||
| Q2 24 | 1.3% | 11.8% | ||
| Q1 24 | 1.4% | 20.8% |
| Q4 25 | 3.94× | 6.28× | ||
| Q3 25 | 2.49× | 3.22× | ||
| Q2 25 | 1.08× | 2.79× | ||
| Q1 25 | 1.77× | 34.71× | ||
| Q4 24 | 4.22× | — | ||
| Q3 24 | 3.19× | — | ||
| Q2 24 | 1.59× | — | ||
| Q1 24 | 0.16× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
